BTG Plc has appointed Susan Foden as a non-executive director, effective 1 March 2015, to help oversee the company’s growth plans. Dr Foden currently holds a number of advisory positions at public and private companies including the UK respiratory company Vectura Group Plc and CD3, a joint venture between Leuven University in Belgium and the European Investment Fund. She has worked in technology transfer and was head of academic liaison at Celltech Ltd, now part of UCB SA. Dr Foden holds an MA and DPhil from the University of Oxford.
BTG announced the appointment on 19 December 2014.
Copyright 2014 Evernow Publishing Ltd